AIMC Topic: Adverse Drug Reaction Reporting Systems

Clear Filters Showing 31 to 40 of 89 articles

Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets.

Pharmaceutical medicine
BACKGROUND: The US Food and Drug Administration (FDA) collects and retains several data sets on post-market drugs and associated adverse events (AEs). The FDA Adverse Event Reporting System (FAERS) contains millions of AE reports submitted by the pub...

Machine Learning Approach for Active Vaccine Safety Monitoring.

Journal of Korean medical science
BACKGROUND: Vaccine safety surveillance is important because it is related to vaccine hesitancy, which affects vaccination rate. To increase confidence in vaccination, the active monitoring of vaccine adverse events is important. For effective active...

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions.

Clinical pharmacology and therapeutics
Adverse drug reaction (ADR) reporting is a major component of drug safety monitoring; its input will, however, only be optimized if systems can manage to deal with its tremendous flow of information, based primarily on unstructured text fields. The a...

Borrowing external information to improve Bayesian confidence propagation neural network.

European journal of clinical pharmacology
PURPOSE: A Bayesian confidence propagation neural network (BCPNN) is a signal detection method used by the World Health Organization Uppsala Monitoring Centre to analyze spontaneous reporting system databases. We modify the BCPNN to increase its sens...

Predicting Adverse Drug Reactions on Distributed Health Data using Federated Learning.

AMIA ... Annual Symposium proceedings. AMIA Symposium
Using electronic health data to predict adverse drug reaction (ADR) incurs practical challenges, such as lack of adequate data from any single site for rare ADR detection, resource constraints on integrating data from multiple sources, and privacy co...

Broad-Spectrum Profiling of Drug Safety via Learning Complex Network.

Clinical pharmacology and therapeutics
Drug safety is a severe clinical pharmacology and toxicology problem that has caused immense medical and social burdens every year. Regretfully, a reproducible method to assess drug safety systematically and quantitatively is still missing. In this s...

A systematic review of natural language processing for classification tasks in the field of incident reporting and adverse event analysis.

International journal of medical informatics
CONTEXT: Adverse events in healthcare are often collated in incident reports which contain unstructured free text. Learning from these events may improve patient safety. Natural language processing (NLP) uses computational techniques to interrogate f...

Comparison of text processing methods in social media-based signal detection.

Pharmacoepidemiology and drug safety
PURPOSE: Adverse event (AE) identification in social media (SM) can be performed using various types of natural language processing (NLP) and machine learning (ML). These methods can be categorized by complexity and precision level. Co-occurrence-bas...

Semi-Supervised Learning Algorithm for Identifying High-Priority Drug-Drug Interactions Through Adverse Event Reports.

IEEE journal of biomedical and health informatics
Identifying drug-drug interactions (DDIs) is a critical enabler for reducing adverse drug events and improving patient safety. Generating proper DDI alerts during prescribing workflow has the potential to prevent DDI-related adverse events. However, ...

Artificial Intelligence for Drug Toxicity and Safety.

Trends in pharmacological sciences
Interventional pharmacology is one of medicine's most potent weapons against disease. These drugs, however, can result in damaging side effects and must be closely monitored. Pharmacovigilance is the field of science that monitors, detects, and preve...